Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether + lumefantrine efficacy and safety for uncomplicated falciparum malaria in Mozambique
ACTRN12616001680459Phase 4Completed
- Sponsor
- Ministry of Health
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether and lumefantrine in malaria and Falciparum malaria (PF), sponsored by Ministry of Health. Primary endpoints: Treatment failure rate and Adequate clinical and parasitological response. Started Feb 2015; status: completed.
02
Drugs
artemetherlumefantrine
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on ACTRN12616001680459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001680459.